Dr. Chiara Corti (Dana-Farber) presents a feasibility study at SABCS 2025 using a machine-learning immune-profiling platform to explore biomarkers predicting immunotherapy benefit in early TNBC. Early signals suggest blood-based immune profiling may complement tissue-based approaches.
